CURE Pharmaceutical Expands U.S. DEA Approval to Manufacture Pharmaceuticals Using Whole Cannabis Plant
March 12, 2019 07:25 ET
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., March 12, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it has broadened its U.S. Drug Enforcement...
Emerald Health Therapeutics Sees Pure Sunfarms Licensed for 1.03 Million Square Feet of Cannabis Cultivation; Full Planting Targeted for End of April
March 11, 2019 07:00 ET
|
Emerald Health Therapeutics Inc.
VICTORIA, British Columbia, March 11, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV:EMH; OTCQX:EMHTF) today announced that its 50%-owned joint venture for large-scale,...
Cannabis Strategic Ventures to Launch Major Cannabis Cultivation with 20 Licenses and 6-Acre Cultivation Site
January 30, 2019 08:30 ET
|
Cannabis Strategic Ventures, Inc.
LOS ANGELES, Jan. 30, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Cannabis Strategic Ventures, Inc. (OTC: NUGS) today announces its plan to break ground on a 6-acre canopy cultivation site in...
Emerald Health sees Expansion of Pure Sunfarms’ Cannabis Cultivation License to 825,000 Square Feet
January 28, 2019 07:00 ET
|
Emerald Health Therapeutics Inc.
VICTORIA, British Columbia, Jan. 28, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. ("Emerald" or the “Company”) (TSXV:EMH; OTCQX:EMHTF) announced that its 50%-owned joint venture...
Emerald Health Sees License Expansion of Pure Sunfarms Cannabis Production Operation to 687,000 Square Feet, one of Largest Production Capacities in Canada
December 10, 2018 07:00 ET
|
Emerald Health Therapeutics Inc.
VICTORIA, British Columbia, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. ("Emerald" or the “Company”) (TSXV:EMH; OTCQX:EMHTF) announced that its 50%-owned joint venture for...
VBI Vaccines Enters into License and Collaboration Agreement with Brii Biosciences for up to $129 Million plus Royalties to Develop a Functional Cure for Hepatitis B
December 06, 2018 08:00 ET
|
VBI Vaccines, Inc.
Upon closing, VBI received gross proceeds of $11 million, consisting of an upfront payment and an equity investment at $3.05 per share from Brii BiosciencesVBI is eligible to receive an additional...
Emerald Joint Venture Receives Licenses from Health Canada to Sell Proprietary Products Supporting the Endocannabinoid System
December 04, 2018 07:00 ET
|
Emerald Health Therapeutics Inc.
Endo Brain recently awarded 2018 SupplySide Editor’s Choice Award for Brain Health Planned mid-2019 product launch will open natural health product, grocery, and pharmacy store channels to Emerald...
Waterloo Brewing preparing for Cannabis Infused Beverage production for October 2019
December 03, 2018 06:00 ET
|
Brick Brewing Co. Limited
KITCHENER, Ontario, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Highlights: Waterloo Brewing has partnered with Cannabis Compliance Inc. (CCI) to secure its research license and standard processing license...
CURE Pharmaceutical Secures U.S. DEA Approval to Manufacture Cannabinoid-based Pharmaceuticals
November 26, 2018 07:25 ET
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., Nov. 26, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it has secured a new registration with the...
BlissCo Receives Cannabis Sales License from Health Canada
November 16, 2018 08:00 ET
|
BlissCo Cannabis Corp.
Not for distribution in the U.S. or to U.S. Newswires VANCOUVER, British Columbia, Nov. 16, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – BlissCo Cannabis Corp. (CSE: BLIS) (OTCQB: HSTRF) (FRA: GQ4B)...